These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18265439)

  • 1. Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer.
    Lin BT
    N Engl J Med; 2008 Feb; 358(6):641-2; author reply 643. PubMed ID: 18265439
    [No Abstract]   [Full Text] [Related]  

  • 2. Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer.
    Berkhof J; Meijer CJ
    N Engl J Med; 2008 Feb; 358(6):642; author reply 643. PubMed ID: 18265441
    [No Abstract]   [Full Text] [Related]  

  • 3. Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer.
    Fields RP
    N Engl J Med; 2008 Feb; 358(6):642-3; author reply 643-4. PubMed ID: 18265442
    [No Abstract]   [Full Text] [Related]  

  • 4. Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer.
    Lytwyn A; Elit L; Sellors JW
    N Engl J Med; 2008 Feb; 358(6):641; author reply 643. PubMed ID: 18256402
    [No Abstract]   [Full Text] [Related]  

  • 5. Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer.
    Frank AP
    N Engl J Med; 2008 Feb; 358(6):642; author reply 643. PubMed ID: 18265440
    [No Abstract]   [Full Text] [Related]  

  • 6. Molecular screening for cervical cancer--time to give up Pap tests?
    Runowicz CD
    N Engl J Med; 2007 Oct; 357(16):1650-3. PubMed ID: 17942878
    [No Abstract]   [Full Text] [Related]  

  • 7. Human papillomavirus and Papanicolaou tests to screen for cervical cancer.
    Naucler P; Ryd W; Törnberg S; Strand A; Wadell G; Elfgren K; Rådberg T; Strander B; Johansson B; Forslund O; Hansson BG; Rylander E; Dillner J
    N Engl J Med; 2007 Oct; 357(16):1589-97. PubMed ID: 17942872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.
    Mayrand MH; Duarte-Franco E; Rodrigues I; Walter SD; Hanley J; Ferenczy A; Ratnam S; Coutlée F; Franco EL;
    N Engl J Med; 2007 Oct; 357(16):1579-88. PubMed ID: 17942871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.
    Wright TC
    Int J Gynaecol Obstet; 2006 Nov; 95 Suppl 1():S239-46. PubMed ID: 17161163
    [No Abstract]   [Full Text] [Related]  

  • 10. Cervical cancer screening from Pap smear to human papillomavirus DNA testing.
    Jin XW; Xu H
    Compr Ther; 2001; 27(3):202-8. PubMed ID: 11569320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
    BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can human papillomavirus DNA testing of self-collected vaginal samples compare with physician-collected cervical samples and cytology for cervical cancer screening in developing countries?
    Bhatla N; Dar L; Patro AR; Kumar P; Kriplani A; Gulati A; Iyer VK; Mathur SR; Sreenivas V; Shah KV; Gravitt PE
    Cancer Epidemiol; 2009 Dec; 33(6):446-50. PubMed ID: 19931499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal pap smears in adolescents.
    Bacon J; Francoeur D; Goldfarb AF; Breech LL
    J Pediatr Adolesc Gynecol; 2003 Jun; 16(3):157-66. PubMed ID: 12804941
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral.
    Kulasingam SL; Hughes JP; Kiviat NB; Mao C; Weiss NS; Kuypers JM; Koutsky LA
    JAMA; 2002 Oct; 288(14):1749-57. PubMed ID: 12365959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV test shows low sensitivity of Pap screen in older women.
    Gyllensten U; Lindell M; Gustafsson I; Wilander E
    Lancet Oncol; 2010 Jun; 11(6):509-10; author reply 510-1. PubMed ID: 20522375
    [No Abstract]   [Full Text] [Related]  

  • 16. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer.
    Wright TC; Denny L; Kuhn L; Pollack A; Lorincz A
    JAMA; 2000 Jan; 283(1):81-6. PubMed ID: 10632284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cytology screening and management of abnormal cytology in adolescent girls.
    Kahn JA; Hillard PJ; ; ;
    J Pediatr Adolesc Gynecol; 2003 Jun; 16(3):167-71. PubMed ID: 12804942
    [No Abstract]   [Full Text] [Related]  

  • 18. ACS updates guideline for the early detection of cervical neoplasia and cancer. American Cancer Society.
    Schroeder BM;
    Am Fam Physician; 2003 May; 67(9):2011, 2015-6. PubMed ID: 12751666
    [No Abstract]   [Full Text] [Related]  

  • 19. Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results.
    Lin CJ; Lai HC; Wang KH; Hsiung CA; Liu HW; Ding DC; Hsieh CY; Chu TY
    Am J Obstet Gynecol; 2011 Jan; 204(1):21.e1-7. PubMed ID: 20833385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASC-US and HPV testing.
    Choma KK
    Am J Nurs; 2003 Feb; 103(2):42-50; 51 quiz. PubMed ID: 12582337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.